SEC Form 4 · accession 0001238120-26-000011
Faeth Therapeutics, Inc. · FTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Phillip B. Donenberg
Director
Period of report
Jun 10, 2026
Accepted (ET)
Jun 12, 2026 · 8:35 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001829802
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $11.41 | Jun 10, 2026 | A | 12,500 | A | — | Jun 9, 2036 | Common Stock | 12,500 | 12,500 | D |
Explanation of responses
- F1The shares subject to the option vest and become exercisable in 12 equal monthly installments over a one year period such that the option is fully vested on June 10, 2027, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
Remarks
Exhibit 24 - Power of Attorney